DMAA NASDAQ
Drugs Made In America Acquisition Corp. Ordinary Shares
1W: +0.4%
1M: +1.1%
3M: +2.1%
YTD: +4.8%
1Y: +6.0%
$10.88
-0.01 (-0.09%)
Weekly Expected Move ±0.3%
$11
$11
$11
$11
$11
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Income Trends
Revenue
$0
+0.0% ▲
Gross Profit
$0
+0.0% ▲
Operating Income
-$479
+0.0% ▲
Net Income
-$479
+0.0% ▲
EPS (Diluted)
$-0.06
+0.0% ▲
EBITDA
$0
+0.0% ▲
Profit Margins
Year-over-Year Growth
View Full Income Statement
| Line Item | FY2024 |
|---|---|
| Revenue | $0 |
| YoY Growth | +0.0% |
| Cost of Revenue | $0 |
| Gross Profit | $0 |
| Gross Margin | — |
| R&D Expenses | $0 |
| SG&A Expenses | $480 |
| Operating Expenses | $480 |
| Operating Income | -$479 |
| Operating Margin | — |
| Interest Expense | $0 |
| Income Before Tax | -$479 |
| Tax Expense | $0 |
| Net Income | -$479 |
| Net Margin | — |
| EPS (Diluted) | $-0.06 |
| EBITDA | $0 |
| Shares Outstanding | 9M |